![Hero Primary](/my/sites/default/files/2024-02/Hero%20Primary.png)
Unlocking the Next Chapter of Kidney Care
Risk Calculator
eGFR is calculated based on serum creatinine and/or cystatin C
eGFR Caculator
eGFR Results
*Computations derived among CKD patients using the data in the EMPA-KIDNEY Trial based on the annual rate of decline in eGFR. Interpret results based on patient risk factors. Results may vary depending on choice of medication and individual risk conditions.
26 Years
No. of Years Saved to Delay End Stage renal Disease (ESRD) using Empagliflozin 10mg
![risk-calc risk-calc](/my/sites/default/files/2024-02/risk-calc.png)
The numbers in the boxes are a guide to the frequency of screening or monitoring (number of times per year).
- LOW RISK (GREEN): Reflects no evidence of CKD by eGFR or albuminuria, with screening indicated once per year.
- MODERATELY INCREASED RISK (YELLOW): Requires measurement at least once a year.
- HIGH RISK (ORANGE): Requires measurement at least twice a year.
- VERY HIGH RISK (RED/DEEP RED): Treat in agreement with a Nephrologist.
- RED: Requires measurement at least 3x a year
- DEEP RED: Requires close monitoring at least 4 times a year (every 1-3 months).
These are general parameters only, based on expert opinion, and underlying comorbid conditions and disease state must be taken into account, as well as the likelihood of impacting a change in management for any individual patient.
Reference
-
1.
de Boer IH et al. Kidney International (2022)
Document ID: SC-MY-04974